Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens

Xiao Liu, Guangxun Gao, Zhengcong Cao et al.|Frontiers in Oncology|2022

Cited by 10